American Gene Technologies is Drug Discovery in United States that focus on gene therapies business. Founded in 2007. They cover business area such as developer, proprietary gene-delivery platform, cell, gene therapy, infectious disease, cancer, inherit disorder, three patent, functionally cure hiv+ individual, its unique immuno-oncology approach, human solid tumor, breast, prostate, a synthetic gene, Phenylketonuria, PKU, physician, effective drug, patient.
2007
( 17 years old in 2024 )
Gene Therapies
-
9713 Key West Avenue
5th Floor
Rockville, MD 20850
United States
Private
developerproprietary gene-delivery platformcellgene therapyinfectious diseasecancerinherit disorderthree patentfunctionally cure hiv+ individualits unique immuno-oncology approachhuman solid tumorbreastprostatea synthetic genePhenylketonuriaPKUphysicianeffective drugpatient
* We use standard office opening hours in near American Gene Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
American Gene Technologies is Drug Discovery business from United States that founded in 2007 (17 years old in 2024), American Gene Technologies business is focusing on Gene Therapies.
American Gene Technologies headquarter office and corporate office address is located in 9713 Key West Avenue 5th Floor Rockville, MD 20850 United States.
American Gene Technologies was founded in United States.
In 2024, American Gene Technologies is currently focus on gene therapies sector.
Above is snippet of Google Trends for "gene therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with American Gene Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.